Related Experiment Video
Updated: Sep 5, 2025

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
Association between serum calcium and in-hospital mortality in critical patients with multiple myeloma: a cohort
Yafei Mao1, Shumin Zhu1, Yulan Geng1
1Department of Laboratory Medicine, The First Hospital of Hebei Medical University, Shijiazhuang, People's Republic of China.
Insights
Serum calcium levels show a nonlinear association with mortality in critically ill multiple myeloma (MM) patients. Levels around 8.40 mg/dL correlate with the lowest risk, with higher levels increasing mortality risk.
Area of Science:
- Critical Care Medicine
- Oncology
- Clinical Biomarkers
Background:
- Elevated serum calcium is a potential biomarker for mortality in multiple myeloma (MM).
- The specific relationship between serum calcium and in-hospital mortality in critically ill MM patients is not well-defined.
Purpose of the Study:
- To investigate the association between serum calcium levels and in-hospital mortality in intensive care unit (ICU) patients with MM.
Main Methods:
- Utilized the MIMIC-IV database to identify MM patients admitted to the ICU.
- Employed multivariable-adjusted Cox regression, curve fitting, and threshold effects analysis.
- Assessed the relationship between serum calcium levels and in-hospital mortality.
Main Results:
- Included 262 MM patients (mean age 72.3 years, 63.4% male); in-hospital mortality was 19.5%.
- A nonlinear relationship was observed between serum calcium levels and in-hospital mortality.
- The lowest risk of mortality was associated with serum calcium around 8.40 mg/dL, with increased risk at higher levels.
Conclusions:
- A nonlinear association exists between serum calcium and in-hospital mortality in critically ill MM patients.
- Serum calcium levels around 8.40 mg/dL are linked to the lowest mortality risk.
- ICU physicians should monitor rising serum calcium levels in MM patients due to increased mortality risk.
Background:
Elevated serum calcium levels may serve as a useful clinical biomarker of mortality in patients with multiple myeloma(MM). However, the clinical significance of the relationship between serum calcium levels and in-hospital mortality in MM patients admitted to the Intensive Care Unit (ICU) remains unclear.
Objectives:
This study aimed to explore the association between serum calcium levels and in-hospital mortality in patients with MM in the ICU.
Methods:
Patients with MM were identified from the Medical Information Mart for Intensive Care IV(MIMIC-IV) database. The outcome was in-hospital mortality. Multivariable-adjusted Cox regression analysis, curve fitting, and threshold effects analysis were used to assess the relationship between serum calcium levels and in-hospital mortality in patients with MM in the ICU.
Results:
Our study included 262 patients with MM with a mean age of 72.3 ± 11.0 years, 63.4% of whom were male. The in-hospital mortality was 19.5% (51/262). The relationship between serum calcium levels and in-hospital mortality was nonlinear. The effect size on the left and right sides of the inflection point, were 0.270 (HR: 0.270, 95% CI 0.106-0.687, P < 0.05) and 2.104 (HR: 2.104, 95% CI 1.069-4.142, P < 0.05), respectively. The results of the sensitivity analysis remained stable.
Conclusion:
Our findings show that a nonlinear relationship exists between serum calcium levels and in-hospital mortality in critically ill patients with MM. A serum calcium level of approximately 8.40 mg/dL was associated with the lowest risk of in-hospital mortality, which increases with rising serum calcium levels, and should be of concern to ICU physicians.
Related Concept Videos
Skeleton and Calcium Homeostasis
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Kidney Disease II: Clinical Manifestations
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Cancer Survival Analysis

